NIH-funded research NIH-funded research

Ethical multimodal AI platform to improve prostate cancer detection with ultrasound

Official title: Ethical Multimodal fusion Artificial Intelligence platform (EMAP) to bridge the gap between imaging modalities: Application to prostate cancer diagnosis.

Funded at Stanford University · NIH-11596787 · Data updated 2026-11-12

A patient-friendly AI system uses ultrasound and MRI information to help doctors better find prostate cancer, aiming to improve accuracy and access.

More Prostate Cancer research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startSeptember 15, 2025
Project endSeptember 14, 2027
Funding year2026
Award (this year)$1,737,835
NIH project number3OT2OD038017-01S1
Project IDNIH-11596787 on NIH RePORTER

Who could benefit from this research

Could help

Men at risk for or suspected of having prostate cancer, including diverse racial/ethnic groups and clinics with varying MRI availability.

Less likely to help

Patients in whom biopsy targets cannot be improved by imaging fusion or those who do not undergo MRI or ultrasound imaging.

What this research studies

This project develops an ethical AI tool that fuses ultrasound and MRI insights to guide prostate cancer targeting, with a focus on fairness, privacy, and real-world use. It aims to perform AI-driven detection enhancements at the time of imaging, even in clinics with limited MRI access. The approach will test how well the AI can improve cancer detection in diverse patient groups while respecting consent and data protection.

Why it matters

Potential benefit: If successful, the platform could lead to more accurate prostate cancer detection and fewer unnecessary biopsies, especially in settings with limited MRI access.

How similar studies have gone: Previous fusion approaches show improved detection when MRI is available, but this project explores a robust AI-driven fusion applicable even where MRI is limited.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Rusu, Mirabela — Stanford University
  • Study coordinator: Rusu, Mirabela

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.